Goingtomeet.com Press

Conference Dates: 5-6th October, 2011
Venue: London, UK
The UK Coalition Government has recently initiated a significant healthcare reform which in reality, presents both major challenges and opportunities to payers, policy-makers and the pharmaceutical industry.

The main components that will affect the pharmaceutical industry include a shift in the role of N.I.C.E. from the gatekeeper of market access to making strong, yet non-binding recommendations regarding cost-effectiveness of treatments. Decisions will be decentralized and delegated to the local-level as “GP Consortia”, who are closer to the patient will be empowered to reimburse based on local need. Furthermore, the existing Pharmaceutical Pricing & reimbursement Scheme (PPRS) will expire and the move will be made to an ambitious value-based pricing model from 2014. For the NHS too, value-based pricing can help to encourage that future applications for reimbursement and premium prices will only be met if the therapy will treat real public health concerns for a rapidly ageing population, improve quality of life and keep patients out of expensive hospital treatments and the burden on health budgets.

Current patient-access (risk-sharing) models may no longer fit under the new decentralised healthcare system and pharmaceutical companies in the UK are restructuring commercial operations to adjust access schemes to new models and decision-making processes.

This event will not only describe current and upcoming healthcare reforms but will also clarify how market-access and reimbursement decisions might proceed and with what effects.

Why Attend?
• Focus on the most influential European market, that is central to global pricing strategy and a traditional pioneer in health technology assessment.
• Evaluate how pricing and reimbursement will be affected under the on-going NHS reform.
• Hear policy makers’ and payers’ views, initiatives and incentives on how the system will work in practice.
• Learn how innovation will be measured and rewarded in the UK in the near future.
• Understand all stakeholders’ roles in the increasingly decentralised decision-making process in the new healthcare reform.
• Find out more about the value-based pricing initiatives and their affect on pricing, market access and competition.
• Network with key decision makers who are involved in designing and implementing this significant reform.

Who will benefit?
Pharmaceutical and Medical devices companies:
Vice-Presidents, Directors, Managers involved in:
Pricing & Reimbursement, Health Economics & Outcomes, Government & Stakeholder Relations, Regulatory Affairs, Medical Affairs, Marketing, Therapy Area Heads, Market Access, Country Managers
Solution providers & consultants:
CEOs, Business Development, Senior Consultants, Regional Heads
Independent Academics, Health Economists, Government Officials, Public & Private Healthcare Providers, Senior Doctors, &Patient Representatives.

Agenda request
To request the full agenda please follow the link:

http://www.nextlevelpharma.com/events/view/pricing_reimbursement_in_the_united_kingdom_during_significant_healthcare_reform

For Booking Information contact:
Erika Vavrovicova

Tel: +421 232 660 382
Fax: +421 2 3301 0331
Email: erika@nextlevelpharma.com
Visit: www.nextlevelpharma.com

New York, NY, May 26, 2009 – IIR, the world’s leading knowledge and skills transfer company, is pleased to announce the former Senator Tom Daschle as keynote speaker of the 14th Annual Summit on the Medicaid Drug Rebate Program, September 21-23, 2009, Chicago, IL.

One of the most influential men in Washington today, Tom Daschle is a former senator whose lifelong passion and commitment to public service and healthcare reform is undeniable. As Senate majority and minority leader from 1994 2005 and the architect of President Obama’s healthcare plan, he is an outspoken advocate for reform, and a well-connected voice between the healthcare industry and Washington policy-makers. His recent book, Critical: What We Can Do About the Healthcare Crisis, offers exciting new solutions on changing America’s healthcare system which provides the framework for Obama’s plan. Senator Daschle is also actively involved in the Bipartisan Policy Center, with Senators Howard Baker, Bob Dole, and George Mitchell, and in both the public and private sector, remains dedicated to finding common ground between conservatives and liberals on the issues that impact us all.

Anne Reel, the Director of IIR’s 14th Annual Medicaid Drug Rebate Summit, says, the pharmaceutical manufacturers are keenly interested in how the current political landscape will change, especially how these changes affect Medicaid reimbursements. Tom Daschle can help the manufacturers understand the new solutions to changing America’s healthcare system and provide the framework for Obama’s Plan. The manufacturers have devoted more internal resources to adapt to new MDRP processes resulting from the DRA and are incurring increased costs due to pending litigations and planning compliance strategies. With insights gathered from our Advisory Board and intensive market research, our annual three-day summit continues to be the top destination for key pharmaceutical manufacturers, state Medicaid professionals, attorneys, experienced consultants, government agency representatives, enforcement agencies, legislative and policy groups.

About the Medicaid Drug Rebate Program Summit

The Medicaid Drug Rebate Program Summit, created and developed by IIR, is the Nation’s largest cross-functional Rebate Program Summit offering CMS representatives explaining implementation strategies for DRA compliance, OIG describing lessons learned from current litigations, updated information by NACDS detailing the AMP litigation, organized dispute resolution meetings facilitated by CMS and more.

 The event is designed for Pharmaceutical Manufacturers Managers and Directors working in Medicaid Rebates, Government Affairs and Contracting, Public Policy, Pricing, Finance/Accounting, Sales/Marketing, Legal Counsel, Pharmacy, Accountant, Pharmacy Contracts and Rebates. To learn more about this event, please visit: www.medicaiddrugrebates.com

 About IIR

IIR is the world’s leading knowledge and skills transfer company with a global network of 47 companies and 112 operating units. Every year, IIR works with 650,000+ business executives providing them with knowledge and skills through training, conferences, seminars, e-Learning, blended solutions, exhibitions, consulting and mentoring. To learn more about IIR, please visit www.iirusa.com.